ELEZANUMAB

UNII: SK1LVT23A1
Preferred Substance Name: ELEZANUMAB

1791416-49-3
ABT-555
AE12-1Y-QL
ELEZANUMAB [INN]
ELEZANUMAB [USAN]
ELEZANUMAB [WHO-DD]
IMMUNOGLOBULIN G1-LAMBDA1, ANTI-(HOMO SAPIENS RGMA (REPULSIVE GUIDANCE MOLECULE FAMILY MEMBER A, REPULSIVE GUIDANCE MOLECULE A, RGMA)), HOMO SAPIENS MONOCLONAL ANTIBODY
IMMUNOGLOBULIN, ANTI-(REPULSIVE GUIDANCE MOLECULE RGMA) (HUMAN MONOCLONAL PR-1432051 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PR-1432051 LIGHT CHAIN, DIMER
PR-1432051

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ELEZANUMAB

Synonyms and Mappings

Resources

Note